ADPT Sale Disclosure
Rubinstein Julie · SEC Form 4 · Filed Oct 8, 2026
Sale
Calculated transaction value
$256.66K
Rubinstein Julie President And COO
Transaction date
Oct 6, 2026
Public filing date
Oct 8, 2026
Filing lag
Filed 2 days later
ADPT daily price context
Close on/before transaction
$26.9
Oct 6, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 9,381 shares @ $27.36
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001780664-26-000037
Filing cohort
Transactions in this filing
Showing 12 of 12
Trades
12
Issuers
1
Estimated value
$1.38M
Buys / sales
0 / 6
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Adaptive Biotechnologies Corp ADPT | Exercise | Oct 8, 2026 | $144.24K |
| Adaptive Biotechnologies Corp ADPT | Sale | Oct 8, 2026 | $304.87K |
| Adaptive Biotechnologies Corp ADPT | Exercise | Oct 8, 2026 | $0 |
| Adaptive Biotechnologies Corp ADPT | Sale | Oct 7, 2026 | $313.66K |
| Adaptive Biotechnologies Corp ADPT | Exercise | Oct 7, 2026 | $144.24K |
| Adaptive Biotechnologies Corp ADPT | Exercise | Oct 7, 2026 | $0 |
| Adaptive Biotechnologies Corp ADPT Current | Sale | Oct 6, 2026 | $256.66K |
| Adaptive Biotechnologies Corp ADPT | Exercise | Oct 6, 2026 | $0 |
| Adaptive Biotechnologies Corp ADPT | Exercise | Oct 6, 2026 | $144.24K |
| Adaptive Biotechnologies Corp ADPT | Sale | Oct 6, 2026 | $26.77K |
| Adaptive Biotechnologies Corp ADPT | Sale | Oct 6, 2026 | $15.23K |
| Adaptive Biotechnologies Corp ADPT | Sale | Oct 6, 2026 | $31.03K |